TLR4 and necrotizing enterocolitis: In human infant and mouse intestinal explants, 2′-FL decreased the severity of necrotizing enterocolitis by binding to the TLR4-myeloid differentiation factor 2-[MD2] complex, which prevented lipopolysaccharide (LPS) binding (9).